abstract |
The present invention relates to therapeutic agents with reduced toxicity, including serum albumin binding peptides (SABP), targeting agents and cytotoxic agents. The invention also relates to methods of reducing toxic agents and methods of treatment with therapeutic agents with reduced toxicity. |